Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.0K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.0K
Censoring Survival Data01:09

Censoring Survival Data

458
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
458
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

17.7K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.7K
Relative Risk01:12

Relative Risk

1.6K
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
1.6K
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

408
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
408
Pareto Chart00:52

Pareto Chart

7.6K
A Pareto chart is a bar graph or a combination of both line and bar graphs. The bar lengths represent the individual values or the frequency, while the lines represent the cumulative total values. In this chart, the longest bars are arranged on the left and the shortest bars on the right, which makes it easier to read and interpret the data. It can also be called a Pareto diagram or Pareto analysis.
The Pareto chart is named after the Italian economist Vilfredo Pareto, who described the Pareto...
7.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cytomegalovirus reactivation in mechanically ventilated patients with or without SARS-CoV-2 infection: A retrospective cohort study.

PloS one·2025
Same author

Valganciclovir Underdosing Is Associated With Cytomegalovirus DNAemia During Universal Prophylaxis: A Real-Life Case Control Retrospective Study.

Journal of medical virology·2025
Same author

Fatal acute respiratory distress syndrome caused by donor-derived human metapneumovirus after lung transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2025
Same author

Corrigendum to "Does SARS-CoV-2 re-infection depend on virus variant?" [Clin Microbiol Infect 27 (9) (2021 Sep) 1374-1375].

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2023
Same author

Dynamics of community-acquired meningitis syndrome outbreaks in southern France.

Frontiers in microbiology·2023
Same author

Acute hepatitis associated with an echovirus 9 infection in a heart transplant recipient.

Journal of medical virology·2022
Same journal

Machine Learning-Based Drug Susceptibility Prediction from Candida Genomic Data.

International journal of antimicrobial agents·2026
Same journal

Vancomycin Penetration into Intra-abdominal Compartments: Site Concentration Disparities and Implications for Dose Optimization in Gram-Positive Infections.

International journal of antimicrobial agents·2026
Same journal

Strain-dependent variability in pharmacodynamic interactions for phage-antibiotic combinations in Pseudomonas aeruginosa.

International journal of antimicrobial agents·2026
Same journal

Carbapenem-resistant Enterobacterales across the UK: a nationwide study of carbapenemase testing and novel antimicrobial activity.

International journal of antimicrobial agents·2026
Same journal

Kidney Injury, Dialysis, and Mortality with Vancomycin Plus Piperacillin-Tazobactam or Cefepime.

International journal of antimicrobial agents·2026
Same journal

Ceftaroline pharmacokinetics on ECMO, a pediatric case report.

International journal of antimicrobial agents·2026
See all related articles

Related Experiment Video

Updated: Dec 25, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

3.2K

SARS-CoV-2: fear versus data.

Yanis Roussel1, Audrey Giraud-Gatineau2, Marie-Thérèse Jimeno3

  • 1Institut Hospitalo-universitaire Méditerranée Infection, Marseille, France; Aix Marseille Université, Institut de Recherche pour le Développement, Assistance Publique-Hôpitaux de Marseille, Microbes Evolution Phylogénie et Infections, Marseille, France.

International Journal of Antimicrobial Agents
|March 24, 2020
PubMed
Summary
This summary is machine-generated.

The novel coronavirus (SARS-CoV-2) may be overestimated, as common coronaviruses cause millions of deaths annually. This study compares SARS-CoV-2 incidence and mortality rates with endemic coronaviruses in OECD countries.

Keywords:
COVID-19CoronavirusSARS-CoV-2

More Related Videos

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.7K
Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
10:25

Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection

Published on: June 5, 2021

5.1K

Related Experiment Videos

Last Updated: Dec 25, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

3.2K
Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.7K
Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
10:25

Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection

Published on: June 5, 2021

5.1K

Area of Science:

  • Epidemiology
  • Infectious Diseases
  • Public Health

Background:

  • Four common coronaviruses cause millions of worldwide cases annually.
  • SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) emerged in China and is spreading globally.
  • Public health responses to SARS-CoV-2 have been significant despite its current low incidence outside Asia.

Purpose of the Study:

  • To compare the incidence and mortality rates of SARS-CoV-2 with four common endemic coronaviruses.
  • To contextualize the threat of SARS-CoV-2 within the broader landscape of respiratory infections.

Main Methods:

  • Comparative analysis of epidemiological data.
  • Examination of incidence and mortality rates in Organisation for Economic Co-operation and Development (OECD) countries.
  • Literature review of common coronavirus circulation and impact.

Main Results:

  • At the time of writing, SARS-CoV-2 accounted for fewer than 4000 deaths.
  • Annual respiratory infections, including those from common coronaviruses, cause approximately 2.6 million deaths globally.
  • Incidence and mortality of SARS-CoV-2 in OECD countries were compared against established coronavirus data.

Conclusions:

  • The public health impact of SARS-CoV-2 may be overestimated when compared to the annual burden of other respiratory infections.
  • Endemic coronaviruses represent a substantial and ongoing global health challenge.
  • Further research is needed to fully understand the long-term epidemiological impact of SARS-CoV-2.